Efficacy and safety of mitomycin C as an agent to treat corneal scarring in horses using an in vitro model

Veterinary Ophthalmology

Volumn 13, Issue 4, 2010, Pages 211-218

  Buss, Dylan G ^a,b   Sharma, Ajay ^c   Giuliano, Elizabeth A ^b   Mohan, Rajiv R ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c University of Missouri   (United States)

Author keywords

Cornea; Equine; Fibroblasts; Mitomycin C; Scarring

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; MITOMYCIN;

ANIMAL; ANIMAL DISEASE; APOPTOSIS; ARTICLE; CELL CULTURE; CORNEA DISEASE; DOSE RESPONSE; DRUG EFFECT; FIBROBLAST; HORSE; HORSE DISEASE; IMMUNOBLOTTING; IN VITRO STUDY; POLYMERASE CHAIN REACTION; SCAR; WESTERN BLOTTING; CICATRIX; CORNEAL DISEASES; DRUG EFFECTS; HORSE DISEASES; VETERINARY;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BLOTTING, WESTERN; CELLS, CULTURED; CICATRIX; CORNEAL DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HORSE DISEASES; HORSES; IMMUNOBLOTTING; MITOMYCIN; POLYMERASE CHAIN REACTION; IN VITRO TECHNIQUES;

EQUIDAE;

EID: 77955150901     PISSN: 14635216     EISSN: 14635224     Source Type: Journal    
DOI: 10.1111/j.1463-5224.2010.00782.x     Document Type: Article

References (38)

1. Haber M, Cao Z, Panjwani N. Effects of growth factors (EGF, PDGF-BB and TGF-beta 1) on cultured equine epithelial cells and keratocytes: implications for wound healing. Veterinary Ophthalmology 2003, 6:211-217.
2. Michau TM, Schwabenton B, Davidson MG. Superficial, nonhealing corneal ulcers in horses: 23 cases (1989-2003). Veterinary Ophthalmology 2003, 6:291-297.
3. Nasisse MP, Nelms S. Equine ulcerative keratitis. Veterinary Clinics North America Equine Practice 1992, 8:537-555.
4. Buss DG, Giuliano EA, Sharma A. Isolation and cultivation of equine corneal keratocytes, fibroblasts and myofibroblasts. Veterinary Ophthalmology 2010, 13:37-42.
5. Buss DG, Sharma A, Giuliano EA. Gene delivery in the equine cornea: a novel therapeutic strategy. American Journal of Veterinary Research 2010
6. Vij N, Sharma A, Thakkar M. PDGF-driven proliferation, migration, and IL8 chemokine secretion in human corneal fibroblasts involve JAK2-STAT3 signaling pathway. Molecular Vision 2008, 14:1020-1027.
7. Jester JV, Petroll WM, Cavanagh HD. Corneal stromal wound healing in refractive surgery: the role of myofibroblasts. Progress in Retinal and Eye Research 1999, 18:311-356.
8. Wilson SE, Mohan RR, Ambrosio R. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Progress in Retinal and Eye Research 2001, 20:625-637.
9. Netto MV, Mohan RR, Ambrosio R. Wound healing in the cornea: a review of refractive surgery complications and new prospects for therapy. Cornea 2005, 24:509-522.
10. Netto MV, Mohan RR, Sinha S. Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, cellular proliferation, haze, and long-term keratocyte density in rabbits. Journal of Refractive Surgery 2006, 22:562-574.
11. Jester JV, Huang J, Barry-Lane PA. Transforming growth factor(beta)-mediated corneal myofibroblast differentiation requires actin and fibronectin assembly. Investigative Ophthalmology and Visual Science 1999, 40:1959-1967.
12. Jester JV, Huang J, Fisher S. Myofibroblast differentiation of normal human keratocytes and hTERT, extended-life human corneal fibroblasts. Investigative Ophthalmology and Visual Science 2003, 44:1850-1858.
13. Maltseva O, Folger P, Zekaria D. Fibroblast growth factor reversal of the corneal myofibroblast phenotype. Investigative Ophthalmology and Visual Science 2001, 42:2490-2495.
14. Boote C, Dennis S, Newton RH. Collagen fibrils appear more closely packed in the prepupillary cornea: optical and biomechanical implications. Investigative Ophthalmology and Visual Science 2003, 44:2941-2948.
15. Conrad GW, Funderburgh JL. Eye development and the appearance and maintenance of corneal transparency. Transactions of the Kansas Academy of Science 1992, 95:34-38.
16. Maurice DM. The transparency of the corneal stroma. Vision Research 1970, 10:107-108.
17. Mohan RR, Hutcheon AE, Choi R. Apoptosis, necrosis, proliferation, and myofibroblast generation in the stroma following LASIK and PRK. Experimental Eye Research 2003, 76:71-87.
18. Mohan RR, Stapleton WM, Sinha S. A novel method for generating corneal haze in anterior stroma of the mouse eye with the excimer laser. Experimental Eye Research 2008, 86:235-240.
19. Leccisotti A. Mitomycin C in photorefractive keratectomy: effect on epithelialization and predictability. Cornea 2008, 27:288-291.
20. Mohan RR, Liang Q, Kim WJ. Apoptosis in the cornea: further characterization of Fas/Fas ligand system. Experimental Eye Research 1997, 65:575-589.
21. Galm U, Hager MH, Van Lanen SG. Antitumor antibiotics: bleomycin, enediynes, and mitomycin. Chemical Reviews 2005, 105:739-758.
22. Nuyts RM, Pels E, Greve EL. The effects of 5-fluorouracil and mitomycin C on the corneal endothelium. Current Eye Research 1992, 11:565-570.
23. Jampel HD. Effect of brief exposure to mitomycin C on viability and proliferation of cultured human Tenon's capsule fibroblasts. Ophthalmology 1992, 99:1471-1476.
24. Kang SG, Chung H, Yoo YD. Mechanism of growth inhibitory effect of Mitomycin-C on cultured human retinal pigment epithelial cells: apoptosis and cell cycle arrest. Current Eye Research 2001, 22:174-181.
25. Wu KY, Hong SJ, Huang HT. Toxic effects of mitomycin-C on cultured corneal keratocytes and endothelial cells. Journal of Ocular Pharmacology and Therapeutics 1999, 15:401-411.
26. Thornton I, Xu M, Krueger RR. Comparison of standard (0.02%) and low dose (0.002%) mitomycin C in the prevention of corneal haze following surface ablation for myopia. Journal of Refractive Surgery 2008, 24:S68-S76.
27. Srinivasan S, Drake A, Herzig S. Photorefractive keratectomy with 0.02% mitomycin C for treatment of residual refractive errors after LASIK. Journal of Refractive Surgery 2008, 24:S64-S67.
28. Shalaby A, Kaye GB, Gimbel HV. Mitomycin C in photorefractive keratectomy. Journal of Refractive Surgery 2009, 25:S93-S97.
29. Rajan MS, O'Brart DP, Patmore A. Cellular effects of mitomycin-C on human corneas after photorefractive keratectomy. Journal of Cataract and Refractive Surgery 2006, 32:1741-1747.
30. Nassaralla BA, McLeod SD, Nassaralla JJ. Prophylactic mitomycin C to inhibit corneal haze after photorefractive keratectomy for residual myopia following radial keratotomy. Journal of Refractive Surgery 2007, 23:226-232.
31. Wilson SE, Mohan RR, Hong JW. The wound healing response after laser in situ keratomileusis and photorefractive keratectomy: elusive control of biological variability and effect on custom laser vision correction. Archives of Ophthalmology 2001, 119:889-896.
32. Sharma A, Mehan MM, Sinha S. Trichostatin a inhibits corneal haze in vitro and in vivo. Investigative Ophthalmology and Visual Science 2009, 50:2695-2701.
33. Chen C, Michelini-Norris B, Stevens S. Measurement of mRNAs for TGFss and extracellular matrix proteins in corneas of rats after PRK. Investigative Ophthalmology and Visual Science 2000, 41:4108-4116.
34. Tuli SS, Liu R, Chen C. Immunohistochemical localization of EGF, TGF-alpha, TGF-beta, and their receptors in rat corneas during healing of excimer laser ablation. Current Eye Research 2006, 31:709-719.
35. Moller-Pedersen T, Cavanagh HD, Petroll WM. Neutralizing antibody to TGFbeta modulates stromal fibrosis but not regression of photoablative effect following PRK. Current Eye Research 1998, 17:736-747.
36. Rayner SG, Van Zyl N. The use of mitomycin C as an adjunctive treatment for equine ocular squamous cell carcinoma. Australian Veterinary Journal 2006, 84:43-46.
37. Majmudar PA, Forstot SL, Dennis RF. Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery. Ophthalmology 2000, 107:89-94.
38. Carones F, Vigo L, Scandola E. Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy. Journal of Cataract and Refractive Surgery 2002, 28:2088-2095.